We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current PKTX market cap is 5.56M. The company's latest EPS is USD -0.0012 and P/E is -16.67.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.2M | -7.64M | -2.33M | -1.91M | -415k |
| Net Income | -4.2M | -7.64M | -2.33M | -1.91M | -415k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 586k | 469k | 446k | 463k | 481k |
| Total Liabilities | 26k | 45k | 93k | 42k | 45k |
| Total Equity | 560k | 424k | 353k | 421k | 436k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 2.54M | -881k | -890k | -805k | -376k |
| Investing | -25k | -70k | -91k | -132k | -59k |
| Financing | 1.12M | 767k | 845k | 905k | 430k |
| Market Cap | 5.56M |
| Price to Earnings Ratio | -16.67 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 200 |
| Price to Book Ratio | 15.54 |
| Dividend Yield | - |
| Shares Outstanding | 338.88M |
| Average Volume (1 week) | 157.34k |
| Average Volume (1 Month) | 140.02k |
| 52 Week Change | -43.25% |
| 52 Week High | 0.03 |
| 52 Week Low | 0.0101 |
| Spread (Intraday) | 0.27 (99.96%) |
| Company Name | Protokinetix Inc (QB) |
| Address |
606 s ninth st las vegas, nevada 89101 7013 |
| Website | https://www.protokinetix.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
